The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate

The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $94.67 million which missed the analyst consensus estimate of $95.16 million by 0.52 percent. This is a 24.25 percent increase over sales of $76.19 million the same period last year.